home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Encapsulation: Formulation, Processing and Testing of Hard Shell Capsules

 
  February 10, 2015  
     
 
CfPA-The Center for Professional Advancement, 90 Minute Accredited Online Training
April 9, 2015 at 11:00 a.m.–12:30 p.m. (ET)


Who Should Attend?
This online training will be valuable to professionals in the following industries: Pharmaceutical, Biotechnology, Nutritional Supplements (Nutraceuticals), Food, Cosmetics, etc.

Professionals in the job functions that would benefit from this course include: Pharmaceutical Scientists, Engineers, Formulators, Chemists, Auditors, Managers, Supervisors

Technicians In departments such as: Research and Development, Manufacturing (Clinical, Commercial), Technical Operations, Regulatory, QA, QC, Clinical, etc.

Course Description
This course will be available On Demand: April 10, 2015

The topics covered in this 90-minute accredited training course include hard shell capsule formulation design and development, process development, manufacture, commercially available processing (filling) equipment, in process tests and finished product tests performed for hard shell capsules, as well as pharmacopoeial and regulatory requirements. The course material will be of immediate and direct benefit to the individual and their company.
 
 
Organized by: CfPA-The Center for Professional Advancement
Invited Speakers:
Dr. Sree Nadkarni, Ph.D.

The course director, Dr. Sree Nadkarni, has a Ph.D. degree in Pharmaceutical Sciences and over 25 years of industrial experience in new drug discovery, development and manufacturing. He has developed formulations and processes and completed scale-up / technology transfer to commercial manufacturing for several drugs on the market. Dr. Nadkarni is currently the Sr. Director of Pharmaceutical Development (CMC) at Biotie Therapies. Previously, he assumed roles of increasing responsibility with multiple pharmaceutical companies including Depomed, FibroGen, CV Therapeutics, Pharmacia / Pfizer and Allergan. Dr. Nadkarni is a member of American Association of Pharmaceutical Scientists. and has been a speaker at various conferences and a program director of a 3-day course on “Tablets & Capsules: Development, Manufacture, Testing and Regulatory Filings”.

 


 
Deadline for Abstracts: n/a
 
Registration: Please click here for registration information.
E-mail: sberg@cfpa.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.